Germany
Japan
United Kingdom
China
Rabbit Polyclonal Anti-INTS1 Antibody
| Applications | IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human INTS1 |
WNT Pathway Markers-Antibodies
View as table DownloadRabbit Polyclonal Anti-RORA rabbit polyclonal antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human RORA |
Rabbit Polyclonal Anti-ROR1 Antibody
| Applications | IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ROR1 |
Rabbit Polyclonal Anti-WNT2 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human WNT2 |
Rabbit Polyclonal Anti-WNT10A Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human WNT10A |
Wnt2 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
FZD4 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the C-terminal region of human FZD4 |
ANAPC5 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of Human ANAPC5 |
APOC2 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of Human APOC2 |
ROR1 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
ROCK2 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of Human ROCK2 |
WNT5B Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of human WNT5B |
SLC25A23 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the N terminal region of human SLC25A23 |
SLC25A23 Antibody - N-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the N terminal region of human SLC25A23 |
TCF4 Antibody - middle region
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of mouse TCF4 |
RORA Antibody - middle region
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of mouse RORA |
FZD4 Antibody - C-terminal region
| Applications | WB |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the C terminal region of mouse FZD4 |
WNT2B Antibody - middle region
| Applications | WB |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of mouse WNT2B |
WNT16 Antibody - middle region
| Applications | WB |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of mouse WNT16 |
ANAPC5 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the C terminal region of human ANAPC5 |
ROCK1 Antibody - middle region
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen is a synthetic peptide directed towards the middle region of human ROCK1 |
ANAPC15 rabbit polyclonal antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human ANAPC15 |
PTK7 rabbit polyclonal antibody
| Applications | IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide of human PTK7 |
WNT3A rabbit polyclonal antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human WNT3A |
TCF25 rabbit polyclonal antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein of human TCF25 |
ANAPC10 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-185 of human ANAPC10 (NP_055700.2). |
| Modifications | Unmodified |
ANAPC11 Rabbit polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-84 of human ANAPC11 (NP_001002245.1). |
| Modifications | Unmodified |
ANAPC13 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-74 of human ANAPC13 (NP_056206.1). |
| Modifications | Unmodified |
ANAPC2 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 400-500 of human ANAPC2 (NP_037498.1). |
| Modifications | Unmodified |
ANAPC5 Rabbit polyclonal Antibody
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-250 of human ANAPC5 (NP_057321.2). |
| Modifications | Unmodified |
DVL2 Rabbit polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-340 of human DVL2 (NP_004413.1). |
| Modifications | Unmodified |
DVL3 Rabbit polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide of human DVL3 |
| Modifications | Unmodified |
FZD1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 210-320 of human FZD1 (NP_003496.1). |
| Modifications | Unmodified |
FZD10 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 135-230 of human FZD10 (NP_009128.1). |
| Modifications | Unmodified |
FZD3 Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 23-205 of human FZD3 (NP_059108.1). |
| Modifications | Unmodified |
FZD4 Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 37-222 of human FZD4 (NP_036325.2). |
| Modifications | Unmodified |
Active filters
Clonalities
- Polyclonal
Filter by
Category
Target Symbol
- MAPK8 (28)
- ROCK2 (17)
- RORA (13)
- WNT1 (12)
- FZD4 (11)
- LEF1 (10)
- WNT2B (10)
- ANAPC5 (9)
- LRP6 (9)
- ROCK1 (9)
- FZD2 (8)
- TCF25 (8)
- WNT10A (8)
- WNT5B (8)
- FZD1 (7)
- FZD8 (7)
- FZD9 (7)
- LRP5 (7)
- ROR1 (7)
- TCF4 (7)
- WNT16 (7)
- WNT2 (7)
- WNT4 (7)
- WNT6 (7)
- ANAPC10 (6)
- DVL2 (6)
- FZD10 (6)
- TCF7L2 (6)
- WNT9A (6)
- DVL3 (5)
- FZD3 (5)
- FZD5 (5)
- FZD6 (5)
- PTK7 (5)
- WNT11 (5)
- WNT3A (5)
- WNT5A (5)
- ANAPC13 (4)
- MAPK10 (4)
- MAPK9 (4)
- TCF21 (4)
- ANAPC11 (3)
- ANAPC15 (3)
- ANAPC2 (3)
- APC2 (3)
- FZD7 (3)
- INTS1 (3)
- ROR2 (3)
- WNT7A (3)
- MAP2K4 (2)
- SLC25A23 (2)
- WNT3 (2)
- WNT7B (2)
- APOC2 (1)
- DVL1 (1)
- JKK-1 (1)
- LRP5L (1)
- MAP2K7 (1)
- RYK (1)
Reactivities
- Human (293)
- Mouse (203)
- Rat (149)
- Bovine (23)
- Dog (16)
- Monkey (14)
- Chicken (12)
- Rabbit (11)
- Gorilla (10)
- Hamster (10)
- Bat (9)
- Horse (9)
- Gibbon (8)
- Pig (7)
- Canis (5)
- Xenopus (3)
- Guinea Pig (2)
- Primate (2)
- C. elegans (1)
- Chimpanzee (1)
- Cow (1)
- Macaque (1)
- Opossum (1)
- Orang-Utan (1)
- Sheep (1)
- Tobacco hornworm (1)
Antibody Hosts
Conjugates
Knockout (KO) Validation
Modifications
Families
- Druggable Genome (204)
- Transmembrane (121)
- Secreted Protein (73)
- ES Cell Differentiation/IPS (70)
- Protein Kinase (61)
- GPCR (44)
- Adult stem cells (34)
- Cancer stem cells (28)
- Stem cell relevant signaling - Wnt Signaling pathway (28)
- Transcription Factors (28)
- Nuclear Hormone Receptor (11)
- Induced pluripotent stem cells (4)
Pathways
- Wnt signaling pathway (204)
- Pathways in cancer (173)
- Basal cell carcinoma (146)
- Melanogenesis (143)
- Colorectal cancer (100)
- Hedgehog signaling pathway (73)
- Focal adhesion (47)
- Progesterone-mediated oocyte maturation (43)
- ErbB signaling pathway (30)
- Fc epsilon RI signaling pathway (30)
- GnRH signaling pathway (30)
- MAPK signaling pathway (30)
- Toll-like receptor signaling pathway (30)
- Epithelial cell signaling in Helicobacter pylori infection (29)
- Neurotrophin signaling pathway (28)
- Adipocytokine signaling pathway (27)
- Insulin signaling pathway (27)
- NOD-like receptor signaling pathway (27)
- Pancreatic cancer (27)
- RIG-I-like receptor signaling pathway (27)
- Type II diabetes mellitus (27)
- Regulation of actin cytoskeleton (23)
- Axon guidance (20)
- Chemokine signaling pathway (20)
- Leukocyte transendothelial migration (20)
- Pathogenic Escherichia coli infection (20)
- TGF-beta signaling pathway (20)
- Vascular smooth muscle contraction (20)
- Cell cycle (16)
- Oocyte meiosis (16)
- Ubiquitin mediated proteolysis (16)
- Endometrial cancer (13)
- Acute myeloid leukemia (10)
- Adherens junction (10)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (10)
- Prostate cancer (10)
- Thyroid cancer (10)
- Notch signaling pathway (8)
- T cell receptor signaling pathway (5)